San Sebastián, Spain and Tessenderlo-Ham, Belgium – 21 November, 2025 – Graphenea Semiconductor, a leading graphene foundry company and Melexis (Euronext Brussels: MELE), a global supplier of micro-electronic semiconductor solutions, announces a strategic collaboration to accelerate the development and evaluation of Melexis’ integrated GFET-on-CMOS platform for advanced biosensing.

The initiative aims to address some of the key hurdles in biosensor adoption: simplifying complex readout electronics and improving sensitivity while ensuring reliability and scalability. By combining Melexis’ expertise in semiconductor integration with Graphenea’s leadership in graphene transistors, the collaboration represents a crucial step from laboratory prototypes to real-world deployment. Applications span from medical diagnostics, such as cancer biomarker detection, neurological and infectious diseases detection, to broader biosensing applications like environmental sensing of PFAS.

Jesus de la Fuente, CEO of Graphenea Semiconductor, said: “This collaboration with Melexis is a significant step forward for the biosensor field. Graphene has long been recognized for its extraordinary sensitivity, but system integration remained a challenge. Melexis’ GFET-on-CMOS platform bridges that gap, and together we are laying the foundation for practical, reliable graphene-based diagnostic tools.”

Axel Fanget, Product Line Manager at Melexis, said: “This collaboration with Graphenea is essential to validate and accelerate the development of our integrated biosensing platform. By working directly with graphene and biosensor specialists, we will significantly enhance our capacity to deliver user-friendly, high-performance, and cost-effective solutions with the potential to revolutionize healthcare and in-vitro diagnostics.”

A Graphene sensor Development (DVK) Kit is available upon request. The DVK includes a standalone readout unit to measure mGFET products and integrated GFET-on-CMOS sensors. For inquiries, please contact digital-health@melexis.com.

About Graphenea Semiconductor

Founded in 2010, Graphenea is a world-leading dedicated graphene foundry company, offering GFET (graphene field effect transistors) chips and custom foundry manufacturing services. Based in San Sebastián, Spain, and Cambridge, MA, USA, Graphenea supports research and industry in over 60 countries. www.graphenea.com

About Melexis

Melexis designs, develops, and delivers edge sensor and driver solutions with a heart for people and the planet. Its mission is to empower engineers to turn their ideas into applications that support the best imaginable future, one that is safe, comfortable, and sustainable.

Melexis specializes in powertrain, thermal management, lighting, e-brake, e-steering, and battery solutions for the automotive sector. It also expands its presence in the emerging markets of a sustainable world, alternative mobility, robotics, and digital health.

Founded in 1989 in Belgium, Melexis has grown to employ over 2,000 people in 12 countries, delivering cutting-edge technology to customers worldwide.

For more information, visit www.melexis.com or follow Melexis on LinkedIn, and YouTube.

Contact Graphenea Semiconductor

Communications Team

Email: info@graphenea.com

Phone: +34 943 023 338

Contact Melexis

Press & Media Relations

Email: brandcomms@melexis.com

Phone: +41 79 174 05 29